Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability.
Wagner F GattazRicardo Saracco-AlvarezClaudiane Salles DaltioMartinus T Van de BiltJose Julian OrtegónSergio Javier Villaseñor-BayardoMario R LouzãHelio ElkisBernardo SoaresPatricia Cabrera JaramilloFabio LawsonLeonardo Díaz-GalvisPublished in: Neuropsychiatric disease and treatment (2020)
Paliperidone palmitate was efficacious in Latin American patients studied with an acute exacerbation and recent diagnosis of schizophrenia, and no new safety signals were identified.